These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 343225)

  • 1. Serum levels of human pancreatic polypeptide in renal disease.
    Hällgren R; Lundqvist G; Chance RE
    Scand J Gastroenterol; 1977; 12(8):923-7. PubMed ID: 343225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum level of immunoreactive gastrin: influence of kidney function.
    Hällgren R; Karlsson FA; Lundqvist G
    Gut; 1978 Mar; 19(3):207-13. PubMed ID: 344160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic polypeptide (PP) (author's transl)].
    Arnold R; McIntosh C; Bothe E; Koop H
    Z Gastroenterol; 1978 May; 16(5):317-24. PubMed ID: 654388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII activity in chronic renal disease.
    Wegmüller E; Grüninger U; Furlan M; Beck EA; Hodler J; Reubi FC
    Nephron; 1981; 28(4):157-62. PubMed ID: 6795517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of glomerular filtration rate by serum creatinine and beta 2-microglobulin.
    Shea PH; Maher JF; Horak E
    Nephron; 1981; 29(1-2):30-5. PubMed ID: 6173777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction.
    Kamata K; Uchida M; Takeuchi Y; Takahashi E; Sato N; Miyake Y; Okubo M; Kodama T; Yamaguchi K
    Nephrol Dial Transplant; 1996 Jul; 11(7):1267-70. PubMed ID: 8672021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma oxalate concentration in chronic renal disease.
    Boer P; van Leersum L; Hené RJ; Mees EJ
    Am J Kidney Dis; 1984 Sep; 4(2):118-22. PubMed ID: 6383028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of a component reacting with antiserum to urinary antitrypsin in health and disease with emphasis on high levels in renal failure.
    Smith JM; Balabanian MB; Freeman RM
    J Lab Clin Med; 1976 Dec; 88(6):905-13. PubMed ID: 825597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta 2 microglobulin in the blood pf patients with chronic renal failure treated by hemodialysis and kidney transplantation].
    Wiecek A; Kokot F; Kochańska-Dziurowicz A; Grzeszczak W; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 1989 Feb; 81(2):100-6. PubMed ID: 2694120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum beta2-microglobulin in the assessment of renal function.
    Bailey RR; Tisch GW; Pearson S
    N Z Med J; 1978 Mar; 87(607):168-70. PubMed ID: 77514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation.
    Ibels LS; Simons LA; King JO; Williams PF; Neale FC; Stewart JH
    Q J Med; 1975 Oct; 44(176):601-14. PubMed ID: 1105647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous pancreatic polypeptide in different vascular beds: relationship to release and degradation in subjects with normal and decreased kidney function.
    Henriksen JH; Schwartz TW; Bülow JB
    Metabolism; 1986 Jun; 35(6):542-6. PubMed ID: 3713514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin and beta 2-microglobulin radioimmunoassays applied to monitoring of renal-allograft function and in differentiating glomerular and tubular diseases.
    Woo J; Floyd M; Cannon DC
    Clin Chem; 1981 May; 27(5):709-13. PubMed ID: 6164506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endocrine profiles in patients with chronic renal insufficiency under periodic hemodialytic treatment and after renal transplantation].
    Orsoni G; Capelli M; Ajuti A; Lazzari E
    G Clin Med; 1981 Apr; 62(4):242-51. PubMed ID: 7021293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta 2 microglobulin in the serum as a parameter of glomerular kidney function in the first days of life].
    Nolte S; Pringsheim W; Künzer W
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):725-8. PubMed ID: 3540620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperparathyroidism and gastroenteropancreatic hormone levels.
    Strodel WE; Vinik AI; Eckhauser FE; Thompson NW
    Surgery; 1985 Dec; 98(6):1101-6. PubMed ID: 2416070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of serum cystatin-C as a marker of the renal function: a comparative evaluation with beta 2-microglobulin, alpha 1-microglobulin and creatinine].
    Hotta O; Yusa N; Mukaiyama I; Taguma Y
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):797-803. PubMed ID: 10655728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta-2-microglobulin estimation as an indicator of the glomerular filtration rate.
    Jialal I; Nathoo BC; Bejai S; Joubert SM
    S Afr Med J; 1982 Jun; 61(25):953-4. PubMed ID: 6178173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.